These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 6292317

  • 21. beta-VLDL and acetylated-LDL binding to pigeon monocyte macrophages.
    Henson DA, St Clair RW, Lewis JC.
    Atherosclerosis; 1989 Jul; 78(1):47-60. PubMed ID: 2667527
    [Abstract] [Full Text] [Related]

  • 22. Interaction of normolipidemic very low density lipoproteins with receptors in human skin fibroblasts.
    Yamamoto M, Ranganathan S, Kottke BA.
    Biochem Int; 1985 Oct; 11(4):573-81. PubMed ID: 3853463
    [Abstract] [Full Text] [Related]

  • 23. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.
    Koo C, Wernette-Hammond ME, Garcia Z, Malloy MJ, Uauy R, East C, Bilheimer DW, Mahley RW, Innerarity TL.
    J Clin Invest; 1988 May; 81(5):1332-40. PubMed ID: 3163347
    [Abstract] [Full Text] [Related]

  • 24. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biochim Biophys Acta; 2000 Feb 24; 1484(1):29-40. PubMed ID: 10685028
    [Abstract] [Full Text] [Related]

  • 25. Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis.
    Barnard GF, Erickson SK, Cooper AD.
    J Clin Invest; 1984 Jul 24; 74(1):173-84. PubMed ID: 6330173
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The beta-VLDL receptor pathway of murine P388D1 macrophages.
    Gianturco SH, Brown SA, Via DP, Bradley WA.
    J Lipid Res; 1986 Apr 24; 27(4):412-20. PubMed ID: 3723014
    [Abstract] [Full Text] [Related]

  • 30. Binding of lipoproteins and regulation of cholesterol synthesis in cultured mouse adipose cells.
    Barbaras R, Grimaldi P, Négrel R, Ailhaud G.
    Biochim Biophys Acta; 1985 Jun 30; 845(3):492-501. PubMed ID: 4005302
    [Abstract] [Full Text] [Related]

  • 31. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD, Novoselov AV, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biol Chem; 2005 May 30; 386(5):441-52. PubMed ID: 15927888
    [Abstract] [Full Text] [Related]

  • 32. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS, Fazio S, Mahley RW.
    J Biol Chem; 1994 May 06; 269(18):13421-8. PubMed ID: 8175773
    [Abstract] [Full Text] [Related]

  • 33. Apolipoprotein E mediates uptake of Sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts.
    Gianturco SH, Gotto AM, Hwang SL, Karlin JB, Lin AH, Prasad SC, Bradley WA.
    J Biol Chem; 1983 Apr 10; 258(7):4526-33. PubMed ID: 6300089
    [No Abstract] [Full Text] [Related]

  • 34. Overproduction of a kinetic subclass of VLDL-apoB, and direct catabolism of VLDL-apoB in human endogenous hypertriglyceridemia: an analytical model solution of tracer data.
    Eaton RP, Allen RC, Schade DS.
    J Lipid Res; 1983 Oct 10; 24(10):1291-303. PubMed ID: 6644179
    [Abstract] [Full Text] [Related]

  • 35. LDL, scavenger, and beta-VLDL receptors on aortic endothelial cells.
    Baker DP, Van Lenten BJ, Fogelman AM, Edwards PA, Kean C, Berliner JA.
    Arteriosclerosis; 1984 Oct 10; 4(3):248-55. PubMed ID: 6324733
    [Abstract] [Full Text] [Related]

  • 36. Glycosylation of LDL decreases its ability to interact with high-affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo.
    Sasaki J, Cottam GL.
    Biochim Biophys Acta; 1982 Nov 12; 713(2):199-207. PubMed ID: 6295495
    [Abstract] [Full Text] [Related]

  • 37. Hypertriglyceridemia: lipoprotein receptors and atherosclerosis.
    Gianturco SH, Gotto AM, Bradley WA.
    Adv Exp Med Biol; 1985 Nov 12; 183():47-71. PubMed ID: 4036704
    [Abstract] [Full Text] [Related]

  • 38. Apolipoprotein E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake.
    Ishibashi S, Yamada N, Shimano H, Mori N, Mokuno H, Gotohda T, Kawakami M, Murase T, Takaku F.
    J Biol Chem; 1990 Feb 25; 265(6):3040-7. PubMed ID: 2303437
    [Abstract] [Full Text] [Related]

  • 39. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
    Medh JD, Fry GL, Bowen SL, Ruben S, Wong H, Chappell DA.
    J Lipid Res; 2000 Nov 25; 41(11):1858-71. PubMed ID: 11060356
    [Abstract] [Full Text] [Related]

  • 40. Cholesterol accumulation in J774 macrophages induced by triglyceride-rich lipoproteins. Comparison of very low density lipoprotein from subjects with type III, IV, and V hyperlipoproteinemias.
    Huff MW, Evans AJ, Sawyez CG, Wolfe BM, Nestel PJ.
    Arterioscler Thromb; 1991 Nov 25; 11(2):221-33. PubMed ID: 1998641
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.